Format

Send to

Choose Destination
See comment in PubMed Commons below
BMC Genomics. 2010 Oct 6;11:540. doi: 10.1186/1471-2164-11-540.

The cost of reducing starting RNA quantity for Illumina BeadArrays: a bead-level dilution experiment.

Author information

  • 1Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK. andy.lynch@cancer.org.uk

Abstract

BACKGROUND:

The demands of microarray expression technologies for quantities of RNA place a limit on the questions they can address. As a consequence, the RNA requirements have reduced over time as technologies have improved. In this paper we investigate the costs of reducing the starting quantity of RNA for the Illumina BeadArray platform. This we do via a dilution data set generated from two reference RNA sources that have become the standard for investigations into microarray and sequencing technologies.

RESULTS:

We find that the starting quantity of RNA has an effect on observed intensities despite the fact that the quantity of cRNA being hybridized remains constant. We see a loss of sensitivity when using lower quantities of RNA, but no great rise in the false positive rate. Even with 10 ng of starting RNA, the positive results are reliable although many differentially expressed genes are missed. We see that there is some scope for combining data from samples that have contributed differing quantities of RNA, but note also that sample sizes should increase to compensate for the loss of signal-to-noise when using low quantities of starting RNA.

CONCLUSIONS:

The BeadArray platform maintains a low false discovery rate even when small amounts of starting RNA are used. In contrast, the sensitivity of the platform drops off noticeably over the same range. Thus, those conducting experiments should not opt for low quantities of starting RNA without consideration of the costs of doing so. The implications for experimental design, and the integration of data from different starting quantities, are complex.

PMID:
20925945
PMCID:
PMC3091689
DOI:
10.1186/1471-2164-11-540
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center